These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5705028)

  • 21. Fixed-dose low-molecular-weight heparin, bemiparin, in the long-term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice: the FLEBUS study.
    Lecumberri R; Rosario E; Pacho J; Rocha E;
    J Thromb Haemost; 2006 Nov; 4(11):2504-8. PubMed ID: 16911674
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of venous thromboembolic (VTE) disease--Part II: Treatment.
    Kayser SR
    Prog Cardiovasc Nurs; 1996; 11(1):36-40, 46. PubMed ID: 8657708
    [No Abstract]   [Full Text] [Related]  

  • 23. [The acute arterial occlusion of the extremities].
    Dost K
    Med Welt; 1969 May; 22():1275-81. PubMed ID: 5801046
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulant and thrombolytic therapies in women.
    Schwartz JB
    J Gend Specif Med; 2002; 5(1):14-8. PubMed ID: 11859682
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypercoagulation and cancer. New treatment possibilities].
    Lykke J; Nielsen HJ
    Ugeskr Laeger; 2004 Aug; 166(33):2781-4. PubMed ID: 15344855
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prolonged anticoagulant treatment by subcutaneous heparin. Experiences in the Resuscitation Center of the Claude Bernard Hospital].
    Amstutz P; Szekely AM; Pocidalo JJ
    Anesth Analg (Paris); 1968; 25(2):203-12. PubMed ID: 5674781
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recent developments in the field of fibrinolytics and anticoagulants].
    Lechner K; Korninger C; Pabinger-Fasching I
    Internist (Berl); 1984 Feb; 25(2):82-7. PubMed ID: 6368457
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fibrinolytic treatment of arterial embolism].
    Dorobisz T; Jaworski Z; Samplawska B; Skóra K; Szydlowski Z
    Pol Tyg Lek; 1969 Apr; 24(15):579-81. PubMed ID: 5801918
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute arterial occlusion of the extremities. Pathogenesis, physiopathology and clinical aspects].
    Kappert A
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:12-28. PubMed ID: 5288600
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current principles of treating acute thromboses and embolisms of the magistral arteries in the extremities].
    Mirza-Avakian GL
    Zh Eksp Klin Med; 1970 Jun; 10(6):53-9. PubMed ID: 5520568
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tactics in choosing anticoagulant and fibrinolytic treatment in severe thromboembolism in district hospital practice].
    Jedlovský A; Kafková A; Zimová E; Trnovec A
    Vnitr Lek; 1980 Jun; 26(6):585-90. PubMed ID: 7405022
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug trials that have influenced our practice in the treatment of venous thromboembolism.
    Kearon C
    Thromb Haemost; 1997 Jul; 78(1):553-7. PubMed ID: 9198214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 34. [Indications and clinical application of thrombosis prophylaxis. I].
    Mittelkötter U; Reith HB; Thiede A
    Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979
    [No Abstract]   [Full Text] [Related]  

  • 35. [Low-molecular heparin in doses adapted to body weight. Management of thromboembolic diseases].
    Internist (Berl); 1999 May; 40(5 Suppl Management):1-16. PubMed ID: 10367262
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of venous thromboembolic disorders: new challenges and opportunities.
    Prandoni P
    Haematologica; 2003 Jun; 88(6):610-3. PubMed ID: 12801835
    [No Abstract]   [Full Text] [Related]  

  • 37. [Value of full heparinization in venoatrial acute thromboembolic insult].
    Hetzel A
    Dtsch Med Wochenschr; 2003 Mar; 128(11):569-70. PubMed ID: 12635032
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of thrombophlebitis and lymphedema of the lower extremities with proteolytic enzymes and heparin electrophoresis].
    Matskiv AS
    Vestn Khir Im I I Grek; 1972 Jun; 108(6):79-81. PubMed ID: 5042722
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of venous thromboembolism after ischemic stroke.
    Kase CS; Pineo GF
    Curr Opin Pulm Med; 2008 Sep; 14(5):389-96. PubMed ID: 18664967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of thrombosamine-heparin in retinal artery thrombosis].
    Dufour D; Constantinides G; Wannebroucq C
    Bull Soc Ophtalmol Fr; 1968 Jan; 68(1):137-40. PubMed ID: 5698079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.